Emerging Technologies
Health care products
The U.S. Food and Drug Administration (FDA) regulates a wide variety of innovative health care technologies, many of which are rapidly evolving and can allow for increasingly personalized care. These products include algorithm-based diagnostic programs that can learn and change in unpredictable ways and medical devices customized and manufactured for individual patients using 3D printers. FDA oversight must adapt to keep pace with this changing field and ensure that the benefits of emerging technologies outweigh their potential risks.
Pew worked to ensure that FDA could review the safety and effectiveness of such technological advances without hindering innovations that could benefit patients.
How FDA Regulates Artificial Intelligence in Medical Products
OUR WORK
Spotlight on Mental Health
MORE FROM PEW
Explore Pew’s new and improved
Fiscal 50 interactive
Your state's stats are more accessible than ever with our new and improved Fiscal 50 interactive:
- Maps, trends, and customizable charts
- 50-state rankings
- Analysis of what it all means
- Shareable graphics and downloadable data
- Proven fiscal policy strategies
Welcome to the new Fiscal 50
Key changes include:
- State pages that help you keep track of trends in your home state and provide national and regional context.
- Interactive indicator pages with highly customizable and shareable data visualizations.
- A Budget Threads feature that offers Pew’s read on the latest state fiscal news.